Cargando…
Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence
Type 2 diabetes mellitus (T2DM) is a risk factor that plays a major role in the onset of heart failure (HF) both directly, by impairing cardiac function, and indirectly, through associated diseases such as hypertension, coronary disease, renal dysfunction, obesity, and other metabolic disorders. In...
Autores principales: | Palazzuoli, Alberto, Iacoviello, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140137/ https://www.ncbi.nlm.nih.gov/pubmed/35522391 http://dx.doi.org/10.1007/s10741-022-10238-6 |
Ejemplares similares
-
Recent advances in pharmacological treatment of heart failure
por: Iacoviello, Massimo, et al.
Publicado: (2021) -
Glucose Metabolism in the Kidney: Neurohormonal Activation and Heart Failure Development
por: Gronda, Edoardo, et al.
Publicado: (2020) -
Vericiguat in Heart Failure: Characteristics, Scientific Evidence and Potential Clinical Applications
por: Vannuccini, Francesca, et al.
Publicado: (2022) -
Heart failure in elderly: progress in clinical evaluation and therapeutic approach
por: Iacoviello, Massimo, et al.
Publicado: (2013) -
ANMCO POSITION PAPER: on administration of type 2 sodium-glucose co-transporter inhibitors to prevent heart failure in diabetic patients and to treat heart failure patients with and without diabetes
por: Gronda, Edoardo, et al.
Publicado: (2021)